Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
Agios Pharmaceuticals Stock Price (Quote) NASDAQ:AGIO
$21.09 ( -0.0474% ) Monday, 23rd May 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $19.97 | $25.10 | Monday, 23rd May 2022 AGIO stock ended at $21.09. This is 0.0474% less than the trading day before Friday, 20th May 2022. During the day the stock fluctuated 4.36% from a day low at $20.62 to a day high of $21.52. |
| 90 days | $19.97 | $32.97 | |
| 52 weeks | $19.97 | $62.16 |
Historical Agios Pharmaceuticals prices
| Date | Open | High | Low | Close | Volume |
| 2022-05-23 | $21.30 | $21.52 | $20.62 | $21.09 | 557 742 |
| 2022-05-20 | $20.85 | $21.14 | $19.97 | $21.10 | 454 188 |
| 2022-05-19 | $21.21 | $21.50 | $20.20 | $20.61 | 644 392 |
| 2022-05-18 | $21.57 | $22.06 | $20.66 | $21.15 | 601 598 |
| 2022-05-17 | $22.98 | $23.26 | $21.84 | $22.33 | 936 297 |
| 2022-05-16 | $21.92 | $22.53 | $21.53 | $22.14 | 390 573 |
| 2022-05-13 | $22.06 | $23.08 | $21.63 | $22.12 | 725 959 |
| 2022-05-12 | $20.20 | $21.85 | $20.20 | $21.41 | 1 164 679 |
| 2022-05-11 | $21.57 | $22.37 | $20.38 | $20.49 | 794 465 |
| 2022-05-10 | $21.61 | $22.70 | $20.46 | $21.79 | 776 585 |
| 2022-05-09 | $22.34 | $22.58 | $20.22 | $20.42 | 616 470 |
| 2022-05-06 | $22.35 | $23.07 | $21.90 | $22.62 | 615 150 |
| 2022-05-05 | $23.00 | $24.29 | $22.01 | $23.00 | 957 851 |
| 2022-05-04 | $23.34 | $24.25 | $22.25 | $24.14 | 496 622 |
| 2022-05-03 | $23.64 | $24.20 | $22.94 | $23.17 | 519 561 |
| 2022-05-02 | $21.83 | $23.59 | $21.72 | $23.58 | 883 652 |
| 2022-04-29 | $22.95 | $23.41 | $21.89 | $21.97 | 637 651 |
| 2022-04-28 | $22.90 | $23.43 | $21.93 | $22.98 | 1 059 830 |
| 2022-04-27 | $22.91 | $23.17 | $22.27 | $22.70 | 538 712 |
| 2022-04-26 | $24.62 | $24.94 | $23.02 | $23.05 | 760 649 |
| 2022-04-25 | $24.17 | $25.10 | $23.73 | $24.95 | 507 617 |
| 2022-04-22 | $24.92 | $25.23 | $24.23 | $24.29 | 164 836 |
| 2022-04-21 | $26.57 | $27.00 | $23.80 | $24.92 | 934 900 |
| 2022-04-20 | $25.79 | $26.86 | $25.48 | $26.33 | 569 300 |
| 2022-04-19 | $25.66 | $27.05 | $25.34 | $26.04 | 1 067 800 |
| 2022-04-18 | $27.74 | $27.74 | $25.30 | $25.57 | 899 800 |
| 2022-04-14 | $29.45 | $29.47 | $27.83 | $27.92 | 392 397 |
| 2022-04-13 | $28.58 | $29.67 | $28.58 | $29.45 | 259 326 |
| 2022-04-12 | $29.10 | $29.98 | $28.00 | $28.47 | 294 029 |
| 2022-04-11 | $28.97 | $29.57 | $28.62 | $28.76 | 304 431 |
| 2022-04-08 | $29.68 | $30.00 | $28.87 | $29.49 | 261 925 |
| 2022-04-07 | $29.82 | $31.16 | $29.16 | $29.66 | 321 700 |
| 2022-04-06 | $30.42 | $30.98 | $29.70 | $29.97 | 603 900 |
| 2022-04-05 | $31.16 | $31.79 | $30.42 | $30.54 | 551 100 |
| 2022-04-04 | $30.12 | $31.45 | $30.10 | $31.42 | 316 300 |
| 2022-04-01 | $29.12 | $30.67 | $28.90 | $30.16 | 276 274 |
| 2022-03-31 | $29.41 | $30.26 | $29.02 | $29.06 | 246 256 |
| 2022-03-30 | $30.14 | $31.13 | $29.22 | $29.37 | 198 123 |
| 2022-03-29 | $28.92 | $30.50 | $28.92 | $30.48 | 375 900 |
| 2022-03-28 | $28.70 | $29.30 | $27.63 | $28.52 | 291 100 |
| 2022-03-25 | $29.82 | $29.85 | $28.71 | $28.79 | 282 200 |
| 2022-03-24 | $29.48 | $29.77 | $28.67 | $29.76 | 264 400 |
| 2022-03-23 | $29.41 | $30.03 | $28.84 | $28.90 | 306 500 |
| 2022-03-22 | $28.78 | $29.88 | $28.70 | $29.72 | 308 261 |
| 2022-03-21 | $29.40 | $29.44 | $28.22 | $28.53 | 422 992 |
| 2022-03-18 | $28.96 | $30.08 | $28.96 | $29.49 | 940 320 |
| 2022-03-17 | $27.35 | $29.75 | $27.35 | $29.36 | 670 800 |
| 2022-03-16 | $27.44 | $28.03 | $26.55 | $27.68 | 786 400 |
| 2022-03-15 | $26.70 | $27.62 | $26.66 | $27.18 | 527 800 |
| 2022-03-14 | $28.65 | $28.65 | $26.51 | $26.68 | 873 000 |
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines for the treatment of cancer and rare genetic metabolic disorders in the United States. The companys product candidates include AG-221, an potent inhibitor of the mutated isocitrate dehydrogenase (IDH) 2 protein that is in Phase I/II, Phase Ib combination, and Phase III IDHENTIFY clinical trials for the treatment of hematologic maligna... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
